Related Experiment Video
Updated: Dec 10, 2025

Location, Dissection, and Analysis of the Murine Stellate Ganglion
Published on: December 22, 2020
Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac
Tyler Shugg1, Andy Hudmon2, Brian R Overholser1,3
1Division of Clinical Pharmacology Indiana University School of Medicine Indianapolis IN.
Insights
Heart failure (HF) alters neurohormonal signaling, affecting cardiac ion channels and increasing arrhythmia risk. This review details how sympathetic nervous system and renin-angiotensin-aldosterone system pathways regulate potassium currents in HF.
Area of Science:
- Cardiology
- Electrophysiology
- Molecular Biology
Background:
- Heart failure (HF) involves neurohormonal imbalances, notably sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system (RAAS) activation.
- Sustained SNS and RAAS activity contribute to HF pathophysiology and increased risk of sudden cardiac death.
- Cardiac electrical remodeling, including altered ventricular ion channel function, underlies HF-associated arrhythmias.
Purpose of the Study:
- To review the regulation of the slow component of the delayed rectifier potassium current (IKs) in the context of HF.
- To elucidate the mechanisms by which HF-associated stimuli impact IKs.
- To summarize intracellular pathways involved in IKs regulation during heart failure.
Main Methods:
- Literature review of studies investigating HF-associated stimuli on IKs.
- Analysis of research on SNS and RAAS signaling in HF.
- Examination of ion channel regulation and cardiac electrical remodeling.
Main Results:
- HF stimuli, including SNS and RAAS activation, modulate IKs.
- Pathological regulation of IKs contributes to action potential duration prolongation and arrhythmogenesis in HF.
- Specific intracellular signaling cascades mediate these regulatory effects.
Conclusions:
- Understanding IKs regulation in HF is crucial for explaining arrhythmia development.
- Targeting IKs pathways may offer therapeutic strategies for HF-related arrhythmias.
- Further research is needed to fully delineate the complex interplay between HF stimuli and cardiac ion channels.
Abstract:
Heart failure (HF) results in sustained alterations in neurohormonal signaling, including enhanced signaling through the sympathetic nervous system and renin-angiotensin-aldosterone system pathways. While enhanced sympathetic nervous system and renin-angiotensin-aldosterone system activity initially help compensate for the failing myocardium, sustained signaling through these pathways ultimately contributes to HF pathophysiology. HF remains a leading cause of mortality, with arrhythmogenic sudden cardiac death comprising a common mechanism of HF-related death. The propensity for arrhythmia development in HF occurs secondary to cardiac electrical remodeling that involves pathological regulation of ventricular ion channels, including the slow component of the delayed rectifier potassium current, that contribute to action potential duration prolongation. To elucidate a mechanistic explanation for how HF-mediated electrical remodeling predisposes to arrhythmia development, a multitude of investigations have investigated the specific regulatory effects of HF-associated stimuli, including enhanced sympathetic nervous system and renin-angiotensin-aldosterone system signaling, on the slow component of the delayed rectifier potassium current. The objective of this review is to summarize the current knowledge related to the regulation of the slow component of the delayed rectifier potassium current in response to HF-associated stimuli, including the intracellular pathways involved and the specific regulatory mechanisms.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology
Mechanism of Cardiac Arrhythmias
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Pathophysiology of Heart Failure
Heart Failure Drugs: Inotropic Agents

